Skip to content

Cardiomyopathy Dilated 2i C5830685

Published: July 22, 2026Updated: August 25, 2026

This cardiomyopathy variant features an enlarged, poorly contracting heart chamber. It may be caused by genetic factors and can affect multiple family members. Treatment focuses on symptom relief, preventing worsening, and supporting heart function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden cardiac death

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Reduced exercise tolerance

(cardiovascular)

Peripheral edema

(cardiovascular)

Abdominal pain

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

ARNI (Angiotensin Receptor-Neprilysin Inhibitor)

Sacubitril/valsartan combines neprilysin inhibition with angiotensin blockade to reduce neurohormonal activation, decrease cardiac remodeling, and improve survival in heart failure patients.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Digoxin

Cardiac glycoside with positive inotropic and negative chronotropic effects that improves contractility and controls heart rate in atrial fibrillation, particularly useful in symptomatic heart failure.

medication

Additional treatment options

Coenzyme Q10 Supplementation

Mitochondrial support supplement that may improve cellular energy production in cardiac muscle, reduce symptoms, and potentially decrease mortality in some heart failure patients.

complementary

BNP/NT-proBNP Laboratory Monitoring

Regular blood testing measuring brain natriuretic peptide levels to objectively assess heart failure severity, track treatment response, and identify disease progression or improvement.

monitoring

Alcohol Abstinence

Complete avoidance of alcohol consumption, as alcohol is directly cardiotoxic and can accelerate ventricular dysfunction progression in alcoholic and non-alcoholic cardiomyopathy alike.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cardiomyopathy Dilated 2i C5830685?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421.

guideline2022
2

McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. Heart Fail Clin. 2020;16(2):199-210.

review2020
3

Mann DL, Greenberg BH, Ducharme A, et al. Efficacy and Safety of Sacubitril/Valsartan in Patients with Dilated Cardiomyopathy: The PARADIGM-HF Subgroup Analysis. Circ Heart Fail. 2021;14(5):e007422.

clinical_trial2021
4

Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic Testing in Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis. Eur J Heart Fail. 2023;25(3):364-378.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Cardiomyopathy Dilated 2i C5830685. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy